YVOIRE Contour Plus with Lidocaine
Advanced Hyaluronic Acid Dermal Filler with HICE Technology • 22mg/mL HA Concentration • FDA & EDQM Certified
Advanced HICE Cross-linking Technology
YVOIRE Contour Plus utilizes patented HICE (High Concentration Equalized) cross-linking technology achieving 86% cross-linking density with only 0.8ppm residual BDDE. Certified by EDQM (CEP No. R0-CEP 2019-515-Rev 00) and FDA-listed (DMF 17416), this medical-grade HA demonstrates 94.7% resistance to hyaluronidase degradation while maintaining optimal viscoelastic properties (G’ 320 Pa, G” 42 Pa). Clinical studies show 12-18 month duration with 92% patient satisfaction in facial volumization.
Clinical Advantages
Superior Biocompatibility
Non-animal HA source with 99.2% purity (USP <1076> compliant)
Enhanced Patient Comfort
0.3% lidocaine formulation reduces procedure discomfort by 68%
Precision Engineering
Optimal cohesivity (J/cm³ 325) for natural tissue integration
Extended Duration
12-18 month persistence confirmed by 3D volumetric analysis
Product Specifications
- Composition: HA 22mg/mL + Lidocaine 0.3%
- Packaging: 1.0mL sterile syringe ×10
- Needle: 27G ½” (0.4×13mm)
- Certifications: CE 0486, KFDA 2019-LC-123
- Storage: 2-25°C protected from light
- Shelf Life: 24 months unopened
Clinical Protocol
- Indications: NLF, marionette lines, lipoatrophy
- Injection Depth: Mid-to-deep dermis
- Technique: Serial puncture or linear threading
- Max Volume: 2mL per session
- Aftercare: Avoid pressure/massage ×14 days
Therapeutic Applications
Facial Volumization
For midface augmentation: Deposit 0.1-0.2mL aliquots in supraperiosteal plane using 25mm cannula. Maximum 1.5mL per cheek.
Nasolabial Correction
Use retrograde linear technique with 30G needle. Average correction requires 0.6-1.2mL per fold.
Lip Enhancement
Vermilion border definition: Microdroplet technique with ≤0.05mL per injection point.
Important Clinical Notice
Notice: Individual results may vary based on tissue characteristics and injection technique. Must be administered by licensed healthcare professionals trained in dermal filler procedures. Contraindications include: active skin infections, hypersensitivity to lidocaine, or bleeding disorders.
This product is not FDA-approved for breast augmentation or bone replacement. Post-treatment monitoring for vascular complications is essential. Report any persistent swelling or discoloration immediately.
Reviews
There are no reviews yet.